Background Take home naloxone (THN) programs have been rapidly upscaled in response to increasing opioid-related mortality. One often cited concern is that naloxone provision …
T Piatkowski, K Seear, S Reeve, E Kill - International Journal of Drug Policy, 2024 - Elsevier
Introduction People who use drugs have a long history of mobilising to reduce harm within their communities, significantly influencing harm reduction efforts globally. Peers with lived …
AL Spector, CL Galletly, EA Christenson… - BMC Public Health, 2022 - Springer
Background Prevention of opioid-involved overdose deaths remains a public health priority in the United States. While expanding access to naloxone is a national public health …
SO Adeosun - Journal of pharmacy practice, 2023 - journals.sagepub.com
The United States opioid epidemic is fueled by illicit opioid abuse and prescription opioid misuse and abuse. Consequently, cases of opioid use disorder (OUD, opioid addiction) …
Providing family members of individuals with opioid use disorders (OUD) naloxone is a cost- effective way to prevent overdose deaths. However, misconceptions and negative attitudes …
Naloxone is a medication used to reverse opioid overdose. Alongside its lifesaving effects, it also has a reputation for producing distress, aggression and occasionally violence upon …
Background Naloxone distribution programs have been a cornerstone of the public health response to the overdose crisis in the USA. Yet people who use opioids (PWUO) continue to …
J Strang - European addiction research, 2022 - karger.com
Abstract Background and Context: Realization of the life-saving potential of “take-home naloxone” has been a personal journey, but it has also been a collective journey. It has been …
Background and aims Although most opioid‐related mortality in Australia involves prescription opioids, most research to understand the impact of naloxone supply on opioid …